Business Context and Reporting Period
This Form 8-K Current Report was filed by InMed Pharmaceuticals Inc. on June 22, 2021. The company is incorporated in British Columbia and its common shares trade on The Nasdaq Stock Market LLC under the symbol INM. The filing primarily serves as a Regulation FD disclosure regarding an upcoming investor presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Eric A. Adams, President and CEO, is scheduled to present live at LifeSciencesInvestorForum.com on June 24, 2021.
- Legal Status of Information: The information in this Item 7.01 and the accompanying news release (Exhibit 99.1) is furnished and not deemed "filed" under Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the news release (Exhibit 99.1) for specific details on the June 24 presentation.
- Confirm the company's status as an emerging growth company (indicated as yes in the filing).
- Review subsequent filings for any financial data or strategic updates discussed during the June 24 presentation.